Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Gallbladder Neoplasms 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 19Cisplatin 11Capecitabine 9Oxaliplatin 7Fluorouracil 5pembrolizumab 4Leucovorin 4Sorafenib 3Magnetic Resonance Spectroscopy 3Erlotinib Hydrochloride 3trifluridine tipiracil drug combination 2regorafenib 2cobimetinib 2atezolizumab 2Trastuzumab 2Taxes 2Specimen Handling 2Platinum 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Lapatinib 2Biopsy 2Bevacizumab 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2zanidatamab 1varlilumab 1vandetanib 1tucatinib 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Gallbladder Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT04740164 2024-11-06

A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP

M.D. Anderson Cancer Center

Phase NA Completed
66 enrolled 15 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡